High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. [electronic resource]
Producer: 20170519Description: 842-852 p. digitalISSN:- 1526-632X
- Adult
- Disability Evaluation
- Disease-Free Survival
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Magnetic Resonance Imaging
- Male
- Multiple Sclerosis, Relapsing-Remitting -- diagnostic imaging
- Transplantation, Autologous -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.